Xenetic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Xenetic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Xenetic Today - Breaking & Trending Today

Xenetic Biosciences, Inc. Announces Reverse Stock Split of Common Stock

FRAMINGHAM, MA / ACCESSWIRE / May 12, 2023 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology technologies ....

Jenene Thomas , Xenetic Biosciences , Xenetic Biosciences Inc View , Empire Stock Transfer Inc , Xenetic Biosciences Inc , Company Dnase , Eastern Time , Nasdaq Capital Market , Empire Stock Transfer , Private Securities Litigation Reform Act , Inc View , Gefallene Big Techs ,

Xenetic Biosciences, Inc. Reports First Quarter 2023 Financial Results and Provides Business Update

- Continued progress with the DNase-based oncology program towards Phase 1 study for the treatment of pancreatic carcinoma and other locally advanced or metastatic solid tumors- Ended the quarter with ....

Xenetic Biosciences , Jenene Thomas , Jeffrey Eisenberg , Scottn Cullison , Reidp Bissonnette , Xenetic Biosciences Inc , Company Dnase , Canadian Intellectual Property Office , Scripps Research Institute , Takeda Pharmaceuticals Co , Xenetic Biosciences Inc View , Scripps Research , Chief Executive Officer , Financial Results , First Quarter , Takeda Pharmaceuticals , Private Securities Litigation Reform Act , Inc View , Gefallene Big Techs ,

Xenetic Biosciences, Inc. Adds Business Development Expertise with Appointment of Scott N. Cullison

Mr. Cullison brings over 20 years of experience in the pharmaceutical industry with a broad range of expertise across business development and strategic planningFRAMINGHAM, MA / ACCESSWIRE / May 3, 2023 ....

Jeffrey Eisenberg , Scottn Cullison , Jenene Thomas , Xenetic Biosciences , Program Management At Bellicum Pharmaceuticals , Business Commercial Development , Targacept Inc , Xenetic Biosciences Inc View , Babcock Graduate School Of Management , Company Dnase , Master Of Business Administration , Wake Forest University , Business Development , Xenetic Biosciences Inc , Business Development Analyst , Business Commercial Development Therapeutic Area Leader , University Of Arizona , Chief Executive Officer , Vice President , Commercial Planning , Peloton Therapeutics , Program Management , Bellicum Pharmaceuticals , Senior Director , Commercial Development , Therapeutic Area Leader ,

Xenetic Biosciences, Inc. Announces Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform

- Collaboration provides a significant step forward in the advancement of Xenetic's DNase-based oncology program towards Phase 1 clinical development- Systemic DNase program initially targeting multi-billion-dollar ....

La Jolla , United States , Xenetic Biosciences , Jeffrey Eisenberg , Jenene Thomas , Research Funding , Scripps Research Institute , Xenetic Biosciences Inc View , Scripps Research , Xenetic Biosciences Inc , Scripps Research Translational Institute , Skaggs Graduate School , Company Dnase , Option Agreement , Chief Executive Officer , Private Securities Litigation Reform Act , Inc View ,

Xenetic Biosciences, Inc. to Present at the Virtual Investor NETs in Cancer Spotlight Event

Live video webcast with moderated roundtable with members of the Xenetic leadership team and recognized oncology leader and NETs researcher, Jonathan Spicer, MD, PhD on Wednesday, March 29th at 11:00 AM ....

Dennis Riedl , Jeffreyf Eisenberg , Jenene Thomas , Xenetic Biosciences , Curtisa Lockshin , Jonathan Spicer , Professor Of Surgery At Mcgill University , Company Dnase , Xenetic Biosciences Inc , Mcgill University Health Center , Thoracic Oncology Network , Xenetic Biosciences Inc View , Virtual Investor , Cancer Spotlight Event , Chief Executive Officer , Chief Scientific Officer , Scientific Advisor , Associate Professor , Mcgill University , Medical Director , Thoracic Oncology , Neutrophil Extracellular Traps , Inc View ,